Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes-Reference-Cited by-同舟云学术

Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes

Published:2012-09-07 Issue:3 Volume:159 Page:311-321
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Saumell Sílvia¹²,Florensa Lourdes¹,Luño Elisa³,Sanzo Carmen³,Cañizo Consuelo⁴,Hernández Jesus M.⁴,Cervera José⁵,Gallart Miguel A.⁶,Carbonell Félix⁷,Collado Rosa⁷,Arenillas Leonor¹,Pedro Carme¹,Bargay Joan⁸,Nomdedeu Benet⁹,Xicoy Blanca¹⁰,Vallespí Teresa¹¹,Raya José M.¹²,Belloch Luis⁵,Sanz Guillermo F.⁵,Solé Francesc¹

Affiliation:

1. Laboratori de Citologia Hematològica, Laboratori de Citogenètica Molecular, Serveis de Patologia i d'Hematologia Cl\xEDnica; Hospital del Mar; GRETHNE, IMIM (Hospital del Mar Research Institute); Barcelona Spain

2. Department of Medicine; Medicine Faculty; Universitat Autònoma de Barcelona; Bellaterra Spain

3. Servicio de Hematología; Hospital Universitario Central de Asturias; Oviedo Spain

4. Servicio de Hematología; Hospital Universitario de Salamanca; Salamanca Spain

5. Servicio de Hematología; Hospital Universitario La Fe; Valencia Spain

6. Servei d'Hematología; Hospital Universitari Arnau de Vilanova; Lleida Spain

7. Servicio de Hematología; Hospital General de Valencia; Valencia Spain

8. Servicio de Hematología; Hospital Son Llàtzer; Mallorca Spain

9. Servei d'Hematología; Hospital Clínic Barcelona; Barcelona Spain

10. Servei d'Hematología; Hospital Universitari Germans Trias i Pujol; Badalona Spain

11. Servei d'Hematología; Hospital Vall d'Hebron; Barcelona Spain

12. Servicio de Hematología; Hospital Universitario de Canarias; La Laguna-Tenerife Spain

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12035/fullpdf

Reference31 articles.

1. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes;Bernasconi;British Journal of Haematology,2007

2. Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: an International Working Group on MDS Cytogenetics Study;Chun;Leukemia Research,2010

3. Regression models and life-tables;Cox;Journal of the Royal Statistical Society. Series B, Statistical Methodology,1972

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response;Frontiers in Oncology;2024-08-02

2. Myelodysplastic Syndrome;Comprehensive Hematology and Stem Cell Research;2024

3. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH);Current Research in Translational Medicine;2023-10

4. Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8;Cancers;2023-07-27

5. Mosaic variant of trisomy on chromosome 8 (Warkany syndrome): report on a rare clinical case in a newborn boy after IVF fertilization;Meditsinskiy sovet = Medical Council;2023-07-27